
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES87
According to their review, there was also some evidence of a difference between the two patient
groups in protection against CV death and total mortality favouring patients with diabetes in
the comparison of ACEI-based regimens vs placebo (see table 12.5.1).234

[@Bakris_2003]

